Denis Claude Roy | BioCanRx

Go Back

Denis Claude Roy

Director of the Cellular Therapy Laboratory; Scientific Director of the Centre de recherche Hôpital Maisonneuve-Rosemont
Full Professor, Université de Montréal
Adjunct professor, McGill University

Cancers of Interest

Blood cancers: leukemia, lymphoma, myeloma, etc.

Research Interests and Clinical Approach

Immunotherapy
Immunotolerancey

Projects at BioCanRx

An Interventional, Open-label, Non-randomized Dose-escalation Phase I Multicenter Clinical Trial of Multi-peptide Anti-minor Histocompatibility Antigen Immunotherapy for the Prevention of Relapse in Patients with High-risk Malignancy Eligible for Matched Related ASCT
Phase I clinical trial of Anti-Minor Histocompatibility Antigen Immunotherapy Broadening the Scope of Application for Precision Therapeutics
DEVELOPING T CELLS THAT TARGET ANTIGENS SPECIFIC TO LYMPHOID CANCERS

Interests

Basic research Blood cancer Cell therapy Clinical research Gene therapy Immunotherapy Molecular and cellular biology Next generation sequencing Regenerative medicine Stem cells Translational research Transplantation